BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33658169)

  • 1. Clinical Outcomes Associated With Chronic Kidney Disease in Elderly Medicare Patients With Multiple Myeloma.
    Li S; Gong T; Kou C; Fu A; Bolanos R; Liu J
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):401-412.e24. PubMed ID: 33658169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis to examine factors associated with mortality in Medicare beneficiaries newly diagnosed with multiple myeloma.
    Yusuf AA; Natwick T; Werther W; Felici D; Mahue M; Bridges KR; Peng Y
    Curr Med Res Opin; 2016 Dec; 32(12):1989-1996. PubMed ID: 27532155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes Following Ischemic Stroke in Older Patients With CKD Stages 4 and 5: A Retrospective Cohort Study.
    Wetmore JB; Herzog CA; Sexter A; Gilbertson DT; Liu J; Kasner SE
    Am J Kidney Dis; 2020 Dec; 76(6):784-793. PubMed ID: 32474166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
    Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
    Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population.
    Singh JA; Cleveland JD
    BMC Nephrol; 2019 Mar; 20(1):93. PubMed ID: 30876398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies.
    Hari P; Romanus D; Luptakova K; Blazer M; Yong C; Raju A; Farrelly E; Labotka R; Morrison VA
    J Geriatr Oncol; 2018 Mar; 9(2):138-144. PubMed ID: 29056336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension.
    Navaneethan SD; Walther CP; Gregg LP; Bansal S; Winkelmayer WC; Nambi V; Niu J
    Am J Kidney Dis; 2021 Nov; 78(5):700-708.e1. PubMed ID: 33905766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geriatric Nutritional Risk Index Is Associated with Unique Health Conditions and Clinical Outcomes in Chronic Kidney Disease Patients.
    Lin TY; Hung SC
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31739530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treated With Apixaban Versus Warfarin.
    Wetmore JB; Yan H; Herzog CA; Weinhandl E; Reyes JL; Roetker NS
    Am J Kidney Dis; 2021 Aug; 78(2):180-189. PubMed ID: 33421454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease.
    Wilson LE; Luo X; Li X; Mardekian J; Garcia Reeves AB; Skinner A
    PLoS One; 2019; 14(11):e0225052. PubMed ID: 31725743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A;
    Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.
    Klarin D; Lancaster RT; Ergul E; Bertges D; Goodney P; Schermerhorn ML; Cambria RP; Patel VI;
    J Vasc Surg; 2016 Nov; 64(5):1295-1302. PubMed ID: 27776697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource use and costs associated with chronic kidney disease in US private insurance patients with multiple myeloma.
    Bhowmik D; Song X; Intorcia M; Kent ST; Shi N
    J Oncol Pharm Pract; 2019 Jun; 25(4):855-864. PubMed ID: 29661050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United States.
    Li S; Natwick T; Liu J; Morrison VA; Vidito S; Werther W; Yusuf AA; Usmani SZ
    J Geriatr Oncol; 2019 May; 10(3):490-496. PubMed ID: 30709612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction.
    Mody P; Wang T; McNamara R; Das S; Li S; Chiswell K; Tsai T; Kumbhani D; Wiviott S; Goyal A; Roe M; de Lemos JA
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):43-50. PubMed ID: 29293980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of adverse events associated with front-line anti-myeloma treatment in Medicare patients with multiple myeloma.
    Chen Y; Lairson DR; Chan W; Du XL
    Ann Hematol; 2018 May; 97(5):851-863. PubMed ID: 29333596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
    Chinnadurai R; Clarke NW; Kalra PA
    BMC Nephrol; 2020 May; 21(1):202. PubMed ID: 32471368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.